This Monkey Ain’t a Junkie

Even though I am not on Twitter, I couldn’t help but notice that today is the unofficial drugmonkeyday!
Many bloggers shared stories of how DrugMonkey’s blog has given them a sense of community, as well as helped with pragmatic advice on NIH-funded sciencing in the US. Here are some of the posts (also a chance to see some blogs you may not regularly follow):

http://datahound.scientopia.org/2016/09/23/drugmonkeyday/

http://chemicalbilology.scientopia.org/2016/09/23/drugmonkeyday/

https://www.edgeforscholars.org/index.html?action=view&id=470

http://neurodojo.blogspot.com/2016/09/day-of-monkey.html

http://bridgeblog.scientopia.org/2016/09/23/thanks-drugmonkey/

https://proflikesubstance.scientopia.org/2016/09/23/unofficial-drugmonkey-day/

http://gertyz.scientopia.org/2016/09/23/appreciation-drugmonkeyday/

https://genrepair.scientopia.org/2016/09/23/thank-you-drugmonkey/

https://blather.scientopia.org/2016/09/23/an-oldish-dog-learning-new-tricks-drugmonkeyday/

When I first started blogging in 2010 on Academic Jungle, DrugMonkey was among the first folks who blogrolled me. I was very much not ready to be read quite so broadly and I did get into trouble a few times over the stupid stuff that I wrote. I still sometimes write stupid stuff. But I also still think very warmly of DM’s welcome to the academic blogosphere.

At that time, DrugMonkey was on ScienceBlogs. Since then, blog collectives have come and gone, and the science blogosphere isn’t today what it used to be be. Many interesting voices have vanished and many others have moved exclusively to Twitter. (I am still keeping my fingers crossed that Female Science Professor will come back to blogging after her administrative sentence service ends.)

DrugMonkey has remained a strong and consistent presence, with his blog that features a unique blend of NIH careerism advice, addiction science, politics, and snark. I am very glad that he keeps writing and has not been entirely lost to the wiles of Twitter.

While I am not a biomedical scientist and do not apply to NIH for funding, I have benefited greatly from DM’s online musings over the years. I feel I now have some idea of how NIH operates and an appreciation for the struggles that the biomedical researchers face, especially those exclusively on soft money — a common setup in biomed, but uncommon in the physical sciences; I would not have had a clue about this reality if it weren’t for DM’s blog. There are notable differences in the field cultures and expectations between the biomedical and physical sciences, but there are also many similarities in how we run our groups, approach science and technical writing. DrugMonkey has provided people like me with a clear picture of professional science on a much broader scale than we would be otherwise be exposed to.

These days, I usually lurk at DM’s place and enjoy the writing. DM’s comment sections are always lively, witty, and informative, a signature of the great community that has assembled around him over the years.

Happy drugmonkeyday, DM! Thank you for writing! 

May all your R01s get funded.

2 comments

  1. As someone in a mostly-NSF funded part of Biology, it’s useful to see your (and previously FSP’s) experience as an NSF funded physical scientist, and compare to DM’s as a hardcore soft money NIH Bio person. Since in some ways people in my field find ourselves somewhere in the middle. 🙂 Personally though, I do not envy the big bucks people – the competition is just insane considering how many grads/postdocs they pump out per PI…

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s